Affiliations: [a] Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology Harbor-UCLA Medical Center, UCLA David Geffen School of Medicine, Torrance, CA, USA
| [b]
Department of Psychiatry, Kaiser Permanente – Baldwin Park, Baldwin Park, CA, USA
| [c]
Department of Psychiatry and Behavioral Sciences, University of Southern California Keck School of Medicine, LA, CA, USA
Correspondence:
[*]
Address for correspondence: Hindi Stohl, MD, Department of Obstetrics and Gynecology, Harbor UCLA Medical Center, 1000 West Carson Street, Box 3, Torrance, CA 90502. USA. Tel.: +1 310 222 3568; +1 310 222 7202; E-mail: hindistohl@gmail.com.
Abstract: Untreated perinatal depression and anxiety increase the risk of pregnancy complications, introducing significant maternal and neonatal complications. Unfortunately, antidepressant treatment with selective serotonin reuptake inhibitors (SSRIs) is similarly associated with adverse perinatal outcomes. Providers should consider all maternal and fetal outcomes when addressing this dilemma.
